All News #Library
Biotech
Centivax Secures $37M To Fast-Track Universal Flu Phase 2 Trial
30 Mar 2026 //
PR NEWSWIRE
Centivax Launches Ph 1 Clinical Trial For Universal Flu Vaccine
12 Feb 2026 //
PR NEWSWIRE
Centivax Secures $45M Series A for Flu Vaccine Development
09 Jul 2025 //
PR NEWSWIRE

Market Place
Sourcing Support